Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Industry Dynamics, Trends and Scope
2.1. Industry Dynamics
2.1.1. Industry driver analysis
2.1.1.1. Rising prevalence of chronic edema, lymphedema, and venous leg ulcers (VLU)
2.1.1.2. Increasing focus on clinical trials
2.1.1.3. Growing demand for home healthcare
2.1.2. Industry restraint analysis
2.1.2.1. Higher cost compared to other alternatives
2.1.3. Industry opportunity analysis
2.1.3.1. Strategic partnerships
2.1.3.2. Expansion opportunities
2.2. Industry Analysis Tools
2.2.1. Industry Analysis - Porter’s
2.2.1.1. Bargaining power of suppliers
2.2.1.2. Bargaining power of buyers
2.2.1.3. Threat of substitutes
2.2.1.4. Threat of new entrants
2.2.1.5. Competitive rivalry
2.2.2. PESTEL Analysis
2.2.2.1. Political & Legal Landscape
2.2.2.2. Economic and Social Landscape
2.2.2.3. Technological landscape
Chapter 3. Adjustable Compression Wraps Market: Indication & Pathology Estimates & Trend Analysis
3.1. Segment Dashboard
3.2. Global Adjustable Compression Wraps Market Movement Analysis
3.3. Global Adjustable Compression Wraps Market Size & Trend Analysis, by Indication/Pathology, 2021 to 2033 (USD Million)
3.4. Venous Leg Ulcers (VLU)
3.4.1. Venous Leg Ulcers (VLU) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
3.5. Deep Vein Thrombosis (DVT) / Post‐Thrombotic Syndrome
3.5.1. Deep Vein Thrombosis (DVT) / Post‐Thrombotic Syndrome Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
3.6. Lymphedema
3.6.1. Lymphedema Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
3.7. Chronic Venous Insufficiency
3.7.1. Chronic Venous Insufficiency Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
3.8. Post-operative Edema
3.8.1. Post-operative Edema Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
3.9. Pregnancy Related Edema
3.9.1. Pregnancy Related Edema Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 4. Adjustable Compression Wraps Market: Compression Class Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Adjustable Compression Wraps Market Movement Analysis
4.3. Global Adjustable Compression Wraps Market Size & Trend Analysis, by Compression Class, 2021 to 2033 (USD Million)
4.4. Class 1
4.4.1. Class 1 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Class 2
4.5.1. Class 2 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Class 3
4.6.1. Class 3 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Class 4
4.7.1. Class 5 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8. Class 6
4.8.1. Class 6 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Competitive Landscape
5.1. Recent Developments & Impact Analysis, By Key Market Participants
5.2. Company/Competition Categorization
5.2.1. Innovators
5.3. Vendor Landscape
5.3.1. List of key distributors and channel partners
5.3.2. Global Key company market share analysis, 2024
5.3.2.1. Medi GmbH & Co.
5.3.2.1.1. Company overview
5.3.2.1.2. Financial performance
5.3.2.1.3. Product benchmarking
5.3.2.1.4. Strategic initiatives
5.3.2.2. Julius Zorn GmbH
5.3.2.2.1. Company overview
5.3.2.2.2. Financial performance
5.3.2.2.3. Product benchmarking
5.3.2.2.4. Strategic initiatives
5.3.2.3. Solventum
5.3.2.3.1. Company overview
5.3.2.3.2. Financial performance
5.3.2.3.3. Product benchmarking
5.3.2.3.4. Strategic initiatives
5.3.2.4. Essity Aktiebolag
5.3.2.4.1. Company overview
5.3.2.4.2. Financial performance
5.3.2.4.3. Product benchmarking
5.3.2.4.4. Strategic initiatives
5.3.2.5. SIGVARIS
5.3.2.5.1. Company overview
5.3.2.5.2. Financial performance
5.3.2.5.3. Product benchmarking
5.3.2.5.4. Strategic initiatives
5.3.2.6. L&R Group
5.3.2.6.1. Company overview
5.3.2.6.2. Financial performance
5.3.2.6.3. Product benchmarking
5.3.2.6.4. Strategic initiatives